Transcranial Magnetic Stimulation isn’t billed like a therapy session, and it isn’t billed like a typical in-office procedure either. It sits in an odd middle ground: a device-driven treatment course that unfolds over 20 to 36 sessions, tied to strict medical-necessity rules, and coded through a tiny family of CPT codes that most billing teams touch far less often than 90837 or a routine E/M visit.
What is TMS Billing ?
TMS billing is the process of submitting and managing insurance claims for Transcranial Magnetic Stimulation services. It involves accurate CPT coding, medical necessity documentation, prior authorization, treatment records, insurance verification, and compliance with payer-specific requirements.
At House of Outsourcing, we provide specialized TMS billing services to help practices manage complex billing requirements and maintain accurate claims. Our team supports claim submission, denial management, A/R follow-up, and reimbursement processes to help reduce payment delays.
Why TMS Billing Behaves Differently From Everything Else in Behavioral Health
A few things make TMS unlike other behavioral health billing:
- It’s a device-based procedure, not a talk-therapy service: The CPT codes describe cortical mapping, motor threshold determination, and magnetic pulse delivery not psychotherapeutic intervention.
- The code set is small on purpose: Three core codes (90867, 90868, 90869) cover an entire six-week treatment course. Get the sequencing wrong once, and it echoes across dozens of claims.
- Medical necessity is unusually specific. Payers generally want documented failure of at least two antidepressant trials at adequate dose and duration before they’ll approve TMS, this isn’t a soft guideline, it’s written directly into Local Coverage Determinations.
- FDA clearance and payer coverage aren’t the same list: TMS has FDA clearances for several conditions, but Medicare and most commercial plans only pay for a narrower set of them.
- The treatment course itself is the billing unit that gets scrutinized. Auditors don’t just look at one claim, they look at whether the whole arc of 90867 followed by dozens of 90868s tells a consistent, medically necessary story.
Where TMS Revenue Commonly Gets Lost
TMS revenue can be lost through authorization issues, coding errors, incomplete treatment documentation, missed billing requirements, claim denials, and delayed A/R follow-up. Identifying these gaps early helps practices protect reimbursement and prevent avoidable revenue loss.
| TMS Billing Area | What Typically Goes Wrong | Revenue Impact |
| Initial session coding | 90867 billed more than once per course | Denial or recoupment on duplicate claims |
| Subsequent sessions | 90868 and 90869 used interchangeably | Underpayment or audit flag |
| Same-day E/M or therapy | Modifier 25 applied without separately documented work | Full claim denial |
| Prior authorization | Assuming Original Medicare rules apply to Medicare Advantage | Session series denied mid-treatment |
| Diagnosis coding | ICD-10 code doesn’t match the failed-medication history in the chart | Medical necessity denial |
| Retreatment courses | New course billed without documenting relapse and prior response | Non-coverage determination |
Who Actually Orders and Delivers TMS? Provider Roles and Supervision Rules
TMS sits under psychiatric medical direction, but the day-to-day delivery often involves more than one type of professional, and payers care about exactly who did what.
- Psychiatrists (MD/DO): Perform the diagnostic workup, confirm treatment-resistant depression, order the treatment course, determine coil placement and motor threshold, and remain responsible for ongoing medical oversight.
- Psychiatric nurse practitioners and physician assistants: In many states and under many payer policies, these practitioners can order and supervise TMS within their scope of practice, though some payers still require a psychiatrist to be involved in the initial diagnostic evaluation.
- TMS technicians: Trained staff — sometimes medical assistants, sometimes nurses — often deliver the daily subsequent sessions (90868) under the required level of physician supervision. The supervision requirement (general vs. direct) varies by payer and by state scope-of-practice law, and it’s one of the first things a payer audit will check.
- Referring therapists and prescribers: Often the ones who document the failed medication trials that establish medical necessity, even if they aren’t the ones delivering TMS.
| Provider Type | Role in TMS Course | Supervision Requirement | Billing Consideration |
| Psychiatrist (MD/DO) | Diagnosis, treatment planning, initial mapping | N/A — supervising provider | Bills 90867 under own NPI |
| Psychiatric NP/PA | May order/supervise per scope of practice | Varies by state and payer | Confirm payer recognizes NP/PA as ordering provider |
| TMS technician | Delivers daily subsequent sessions | General or direct supervision, payer-dependent | Physician/NP must remain billing provider of record |
| Referring PCP or therapist | Documents medication history | Not involved in delivery | Records must be available to support medical necessity |
The TMS CPT Code Family: 90867, 90868, and 90869 Explained Simply
Nearly the entire TMS treatment course is billed under three codes, and the differences between them come down to what happens during the session, not how long it lasts.
| CPT Code | Official Description | When It’s Used | Reporting Limit |
| 90867 | TMS treatment; initial, including cortical mapping, motor threshold determination, delivery and management | Once, at the start of the course | Once per episode of care; not more than once in a six-week period |
| 90868 | TMS treatment; subsequent delivery and management, per session | Routine daily sessions after the initial visit | Once per session, for the majority of the course |
| 90869 | TMS treatment; subsequent motor threshold re-determination with delivery and management | When the motor threshold needs to be re-checked mid-course (e.g., after a treatment gap or clinical change) | Occasional — only when re-determination is clinically indicated and documented |
Billing the Initial Session Correctly: What 90867 Actually Requires
The first TMS visit isn’t just “session one” — it’s a distinct clinical event that includes cortical mapping, calculating the patient’s motor threshold (the minimum stimulation intensity that produces a visible muscle twitch), and delivering the first treatment dose, typically at 110–120% of that threshold. For 90867 to hold up under review, the note generally needs to show:
- The diagnostic workup and confirmation of treatment-resistant depression (or another covered indication), including which medications were tried, at what doses, and for how long
- The specific motor threshold value obtained, and how it was determined
- Coil type, target location, and stimulation parameters selected for the course
- Documentation that informed consent was obtained
- The credentials of the provider performing the mapping — unqualified or inadequately supervised staff performing this step is a frequently cited reason for claim recoupment
A second 90867 is only appropriate when a genuinely new treatment episode begins, for example, a new depressive episode following a period of remission not simply because a patient took a short break mid-course.
Subsequent Sessions: Telling 90868 and 90869 Apart Without Guessing
Once the initial mapping is complete, the bulk of the treatment course, often 29 to 35 sessions, gets billed under 90868. This is the workhorse code of TMS billing, and it should read almost identically, session to session, in terms of what’s documented: frequency (Hz), stimulation intensity as a percentage of motor threshold, number of pulses delivered, and coil location.
90869 is the exception code, not the default. It applies only when the motor threshold is being re-determined mid-course, something that typically happens after a significant treatment interruption, a notable weight change, or another clinical reason that could affect stimulation intensity. Per Medicare’s coverage article, 90869 should never appear on the same claim as 90867 or 90868.
| Code | What’s Happening Clinically | Documentation Focus | Common Billing Risk |
| 90868 | Routine daily/weekly session, no threshold change | Frequency, intensity, pulse count, coil site | Missing pulse count or intensity turns a clean note into a denial risk |
| 90869 | Motor threshold is being re-checked | Clinical rationale for re-determination, new threshold value | Billing this routinely instead of only when clinically justified |
A practical rule of thumb: if a 36-session course produces anything other than roughly “1 unit of 90867 + up to 35 units of 90868, with 90869 appearing only occasionally,” that pattern is exactly what a payer’s claims-scrubbing algorithm is built to flag.
When Medication Management or Psychotherapy Happens Alongside a TMS Visit
TMS visits are often brief check-ins layered on top of a broader psychiatric relationship, which raises the same question payers ask across behavioral health: is there a separately identifiable service happening, or is this just the built-in clinical work that already comes with the procedure?
CPT guidance is direct on this point: routine evaluation and management activities directly related to cortical mapping, motor threshold determination, or TMS delivery are not separately billable. If a significant, separately identifiable E/M or psychotherapy service occurs on the same day say, the psychiatrist adjusts a medication regimen or addresses a new clinical issue unrelated to the TMS delivery itself that service can be reported in addition, generally with modifier 25 appended to the E/M code (never to the TMS code).
| Same-Day Scenario | Codes Involved | Documentation Needed | Common Error |
| Medication check during TMS course | 90868 + 99213/99214-25 | Distinct history/exam/MDM unrelated to the TMS delivery itself | Modifier 25 used without a truly separate, documented E/M service |
| Brief psychotherapy add-on same day | 90868 + 90833/90836/90838 | Separate psychotherapy note with start/stop times | Time for TMS delivery and psychotherapy overlapping in the note |
| Routine TMS check-in only | 90868 alone | Standard session parameters | Billing an E/M code for work that’s already bundled into 90868 |
Medical Necessity: What Payers Actually Require Before Approving TMS
This is the part of TMS billing that has the least room for interpretation. Nearly every Local Coverage Determination and most commercial medical policies modeled after them requires documented failure of prior treatment before TMS is considered reasonable and necessary.
Typical criteria include:
- A diagnosis of major depressive disorder, single or recurrent episode, without psychotic features
- Documented failure of at least two adequate antidepressant trials (different pharmacologic classes, adequate dose, adequate duration — generally four weeks or more), or clear documentation of intolerance
- Absence of exclusionary conditions — active psychotic symptoms, certain neurological conditions, seizure history, or implanted metal/magnetic-sensitive devices near the treatment site
- An in-person evaluation and order from a qualified prescriber (typically a psychiatrist)
- For retreatment: documentation that the patient responded to a prior TMS course and has since relapsed
ICD-10-CM Coding: Does the Diagnosis Actually Support TMS?
Diagnosis coding for TMS isn’t just about picking a depression code, it needs to reflect the severity and treatment history that medical necessity rules require.
| Indication | Common ICD-10-CM Codes | Coverage Note |
| Major depressive disorder, single episode | F32.0–F32.9 | Severity and treatment-resistance documentation still required |
| Major depressive disorder, recurrent | F33.0–F33.9 | F33.2 (severe, without psychotic features) is frequently referenced in payer policy examples |
| Obsessive-compulsive disorder | F42.2, F42.3, F42.4, F42.8, F42.9 | FDA-cleared, but Medicare often treats this as investigational — verify payer-specific coverage first |
| Nicotine dependence (smoking cessation) | F17.200–F17.299 | FDA-cleared for short-term use; commercial coverage is inconsistent |
| Depression with anxious distress | Coded under the applicable F32/F33 code plus supporting documentation | Payer recognition of this specific indication varies |
A diagnosis code alone won’t carry a claim. The chart needs to connect that diagnosis to a documented history of treatment failure — the two have to tell the same story, or the claim is vulnerable to a medical-necessity denial even when the code itself is technically correct.
FDA Clearance vs. Payer Coverage: Two Different Lists That Get Confused Constantly
This is one of the most common sources of billing surprises in TMS, and it’s worth being blunt about it: FDA clearance does not mean a payer will pay for it.
TMS has picked up several FDA clearances over time — major depressive disorder in 2008, followed by expansions for OCD, migraine, short-term smoking cessation, depression with anxious distress, and more recently adolescent MDD. That’s a genuinely broad list of cleared uses. But Medicare’s coverage policies, and most commercial medical policies built around them, remain focused almost entirely on treatment-resistant major depressive disorder in adults. OCD, migraine, and smoking cessation are frequently treated as investigational for coverage purposes, even where the device itself is legally cleared to treat them.
Before scheduling a course of TMS for anything other than MDD, it’s worth verifying — in writing, from the specific payer — whether that indication is actually reimbursable, rather than assuming clearance equals coverage.
Documentation That Actually Supports a TMS Claim
Auditors reviewing TMS claims aren’t looking for eloquent notes; they’re looking for specific, repeatable data points that prove the service billed is the service delivered.
| Documentation Element | Why It Matters | Common Gap |
| Motor threshold value | Establishes the individualized dosing basis for the whole course | Value recorded once, never referenced again |
| Stimulation frequency and intensity | Confirms the treatment matches the ordered protocol | Generic templated language with no session-specific numbers |
| Pulse count per session | A core billing detail payers specifically check for | Left blank or copied forward without verification |
| Coil location/target | Ties the session to the clinical indication being treated | Inconsistent target documented across the course |
| Failed medication trial history | Establishes medical necessity for the entire course | Summarized vaguely (“multiple medications tried”) instead of named, dosed, and dated |
| Informed consent | A compliance requirement independent of billing | Consent obtained once but not clearly referenced in the initial note |
| Safety screening for contraindications | Required given magnetic-field risk with implants | Screening not re-verified if new implants occur mid-course |
Safety Screening, Informed Consent, and HIPAA — Compliance That Sits Alongside Billing
TMS carries a specific safety profile tied to its magnetic field, and the documentation trail around it isn’t optional paperwork it’s part of what makes the claim defensible.
- Contraindication screening for implanted magnetic-sensitive devices, cochlear implants, aneurysm clips, or other metal near the treatment site needs to be documented at intake and re-confirmed if the patient’s medical history changes mid-course.
- Informed consent covering the procedure, expected course length, and known risks (mild scalp discomfort, headache, and a small seizure risk) should be captured in writing before the first session and referenced in the clinical note.
- HIPAA safeguards apply throughout — treatment records, motor threshold data, and behavioral health diagnoses are all protected health information, and that’s especially relevant when TMS practices share records between a referring prescriber, a technician team, and billing staff. Access to these records should be limited to those with a legitimate treatment or billing need, consistent with the HIPAA Privacy Rule’s minimum-necessary standard, and any data shared with a billing vendor should be covered under a signed Business Associate Agreement.
- State scope-of-practice law governs what a technician can do independently versus under direct physician supervision — this varies by state and should be checked against both licensing board rules and the specific payer’s supervision requirements, not assumed to be uniform.
Prior Authorization and Insurance Verification: “Covered” Isn’t the Same as “Approved”
TMS coverage varies enough between payers, and even between plans from the same payer, that eligibility verification alone doesn’t tell the whole story.
- Original Medicare generally doesn’t require prior authorization for TMS — claims are reviewed against the applicable LCD after the fact.
- Medicare Advantage plans frequently do require prior authorization, even though the underlying benefit follows Medicare’s coverage rules.
- Medicaid coverage varies by state — some states have added TMS coverage for treatment-resistant MDD only within the last year or two, with their own documentation requirements layered on top of federal guidance.
- Commercial payers publish their own medical policies, which may differ from Medicare’s failed-trial threshold, session limits, or accepted diagnoses.
- Session limits and course length should be confirmed before treatment starts — some payers cap the number of sessions per course or per year.
| Verification Question | Why It Matters | Risk If Skipped |
| Does this plan require prior auth for 90867–90869? | MA and commercial plans often do, even when Original Medicare doesn’t | Course started, then denied mid-treatment |
| How many failed medication trials does this payer require? | Thresholds differ from Medicare’s LCD language | Approved diagnosis doesn’t match payer’s documentation standard |
| Is there a session or annual limit? | Some plans cap total TMS sessions | Sessions delivered beyond the covered limit go unpaid |
| Does the plan cover retreatment courses? | Retreatment criteria differ from initial-course criteria | Second course denied without prior-response documentation |
| Is TMS technician supervision billed correctly under this plan’s rules? | Supervision requirements vary by payer and state | Claims denied over supervision-level mismatch |
Retreatment and Maintenance TMS: When a New Course Is Actually Billable
Depression can relapse after a successful TMS course, and payers do allow retreatment — but only under specific conditions. Generally, retreatment is considered reasonable and necessary when the patient met the original coverage criteria, responded meaningfully to that prior course (often defined as a significant improvement on a standardized depression rating scale), and has since relapsed.
Ongoing maintenance TMS — low-frequency sessions meant to sustain remission indefinitely rather than treat an active relapse — is treated differently. Several Medicare LCDs specifically state that maintenance therapy isn’t currently supported by the evidence base and is considered not reasonable and necessary for coverage purposes. That distinction between “retreatment for a documented relapse” and “ongoing maintenance” is one billing teams need to get right before scheduling a second course, not after the claims start coming back denied.
Why Your TMS Claims Get Denied
TMS claims can be denied due to missing prior authorization, insufficient medical necessity documentation, incorrect CPT coding, incomplete treatment records, or payer-specific requirements. Reviewing these details before submission can help reduce avoidable denials and reimbursement delays.
| Denial Reason | Likely Cause | Prevention |
| Duplicate 90867 | Initial code billed more than once in a course | Confirm only one 90867 per episode before submitting |
| Medical necessity denial | Diagnosis and failed-trial documentation don’t align | Cross-check chart notes against the payer’s specific LCD/medical policy before the course begins |
| Modifier 25 rejection | E/M billed same-day without a clearly separate, documented service | Keep procedure notes and E/M notes distinct, each with its own clinical reasoning |
| 90869 billed with 90867 or 90868 same day | Coding error or misunderstanding of the “not in conjunction with” rule | Build a claim-scrubbing edit to catch this combination before submission |
| Missing session-level detail | Pulse count, intensity, or coil location absent from the note | Use a structured TMS-specific note template for every session |
| Authorization lapse mid-course | Authorization obtained for initial sessions but not the full course | Confirm the authorized session count matches the ordered course length |
| Supervision-level mismatch | Technician delivering sessions under the wrong supervision level for that payer | Verify payer-specific and state-specific supervision rules before staffing sessions |
Credentialing for Your TMS Practice
TMS credentialing has its own wrinkles beyond standard psychiatric provider enrollment, because payers often want confirmation that the ordering provider has specific TMS training and that the facility itself is set up to deliver the service.
| Credentialing Step | Responsible Party | Common Delay | Impact |
| Psychiatrist enrollment with TMS-specific attestations | Credentialing team + provider | Payer requests device-specific training certificates | Program can’t bill until enrollment clears |
| Facility/place-of-service registration | Practice administration | Office vs. outpatient facility designation mismatch | Claims rejected on place-of-service edits |
| Technician certification tracking | Practice administration | Missing renewal dates for device-specific training | Supervision compliance gap discovered during audit |
| Medicare and Medicaid enrollment | Credentialing team | State Medicaid TMS coverage added recently, enrollment lagging | Newly eligible patients can’t be billed yet |
| CAQH profile maintenance | Provider + credentialing team | Attestation lapses every 120 days | Commercial claims pend for credentialing verification |
TMS Across Different Practice Settings: One Workflow Doesn’t Fit Every Setup
A solo psychiatry practice running its first TMS chair looks nothing like a multi-location TMS-only clinic or a hospital-based interventional psychiatry program, and the billing workflow needs to reflect that.
| Practice Setting | Typical Structure | Billing Complexity | Revenue-Cycle Focus |
| Solo/small psychiatry practice adding TMS | Psychiatrist orders and often delivers sessions directly | Moderate — low volume, but every denial hits harder proportionally | Getting the initial credentialing and payer verification right before the first patient starts |
| Dedicated TMS clinic (multi-chair) | Psychiatrist oversight, technician-delivered daily sessions | High — volume magnifies any coding or supervision error | Standardized session documentation templates and claim-scrubbing edits |
| Hospital-based or academic interventional psychiatry program | Multiple prescribers, research and off-label protocol use common | Highest — off-label protocols, accelerated courses, complex payer mix | Strong documentation for evidence-based rationale on newer protocols |
Is Your TMS Program Getting Paid for Every Session You’re Delivering?
Between motor thresholds, session sequencing, payer-specific medical necessity thresholds, and the compliance layer sitting underneath all of it, TMS billing asks a lot of a team that may only see a handful of these claims a month. That’s usually where revenue quietly slips, not from one dramatic error, but from small, recurring gaps across a treatment course that only becomes visible once the denials start stacking up.
House of Outsourcing works alongside behavioral health and psychiatric practices to close exactly those gaps, across the full TMS revenue cycle:
| Billing Challenge | What It Costs the Practice | How House of Outsourcing Helps |
| Eligibility and benefits verification | Sessions delivered before confirming coverage | Payer-specific verification before treatment starts, including MA and Medicaid nuances |
| Prior authorization | Mid-course denials when auth doesn’t cover the full session count | Authorization tracked against the full ordered course, not just the first visit |
| TMS-specific coding (90867–90869 + add-ons) | Duplicate or mismatched codes across a treatment course | Coders trained specifically on TMS sequencing and CMS coverage articles |
| Charge entry and claims submission | Manual entry errors across dozens of sessions per patient | Structured workflows built around the TMS code family |
| Payment posting | Underpayments going unnoticed across long treatment courses | Course-level reconciliation, not just claim-by-claim posting |
| Denial management | Modifier 25 and medical-necessity denials left unappealed | Targeted appeals backed by documentation review |
| A/R follow-up | Aging claims tied up in payer-specific authorization disputes | Dedicated follow-up on behavioral-health and device-based claims |
| Credentialing and payer enrollment | Delayed program launch or newly eligible patients unbillable | TMS-specific attestations and Medicaid enrollment tracked proactively |
| Reporting and revenue-cycle analysis | No visibility into where a TMS program is actually losing revenue | Course-level reporting that shows denial patterns before they compound |
If your practice is running — or planning to launch — a TMS program, getting the billing infrastructure right from day one is a lot less costly than untangling it six months and two hundred claims later.
